ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0FDB Navamedic Asa

12.10
0.00 (0.00%)
14 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Navamedic Asa LSE:0FDB London Ordinary Share NO0010205966 NAVAMEDIC ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 12.10 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 382.14M 29.43M 1.7083 7.08 208.46M

Navamedic ASA: Invitation to 2023 2nd quarter presentation

07/08/2023 11:40am

PR Newswire (US)


Navamedic Asa (LSE:0FDB)
Historical Stock Chart


From May 2023 to May 2024

Click Here for more Navamedic Asa Charts.

OSLO, Norway, Aug. 7, 2023 /PRNewswire/ -- Navamedic ASA (OSE: Nava) will be presenting its second quarter 2023 results and publish its first half 2023 report on Friday, August 11, 2023. The presentation will be held at Haakon VIIs gate 2 in Oslo and the event will start at 08.30 CET. A link to the webcast and the presentation will be available through the Navamedic web site on the following link: https://navamedic.com/investors/financial-results/. 

For further information, please contact:

Kathrine Gamborg Andreassen, CEO, +47 951 78 680 E-mail: kathrine@navamedic.com

Lars Hjarrand,CFO, +47 917 62 842 E-mail: lars.hjarrand@navamedic.com

About Navamedic: Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com 

Cision View original content:https://www.prnewswire.co.uk/news-releases/navamedic-asa-invitation-to-2023-2nd-quarter-presentation-301894462.html

Copyright 2023 PR Newswire

1 Year Navamedic Asa Chart

1 Year Navamedic Asa Chart

1 Month Navamedic Asa Chart

1 Month Navamedic Asa Chart

Your Recent History

Delayed Upgrade Clock